(Q36407624)

14 August 2017

1 reference

title

Erectile dysfunction in Parkinson's disease (English)

1 reference

14 August 2017

1 reference

1 reference

Papatsoris AG

1

1 reference

14 August 2017

Deliveliotis C

series ordinal

2

1 reference

14 August 2017

Singer C

series ordinal

3

1 reference

14 August 2017

Papapetropoulos S

series ordinal

4

1 reference

14 August 2017

language of work or name

English

0 references

publication date

28 February 2006

1 reference

14 August 2017

1 reference

14 August 2017

67

1 reference

14 August 2017

3

1 reference

14 August 2017

447-451

1 reference

Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Health issues of men: prevalence and correlates of erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Sildenafil citrate: lessons learned from 3 years of clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Ageing and Parkinson's disease: substantia nigra regional selectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Sexual function in patients with Parkinson's disease and their partners

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Sexuality and parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Parkinsonism: onset, progression, and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

The risk of bladder and autonomic dysfunction in a community cohort of Parkinson's disease patients and normal controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Sexual Dysfunction in Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Quality of sexual life in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Psychotic symptoms in Parkinson's disease. From description to etiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Sexuality in young patients with Parkinson's disease: a population based comparison with healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Amygdala pathology in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Autonomic dysfunctions in idiopathic Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Neurologic erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Neuropathology of autonomic nervous system in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Distribution of dopamine immunoreactivity in the rat, cat and monkey spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Localization of dopamine D2 receptor in rat spinal cord identified with immunocytochemistry and in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Opposite influences of dopaminergic receptor subtypes on penile erection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Apomorphine-induced penile erections in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Dopaminergic neurotransmission at the paraventricular nucleus of hypothalamus in central regulation of penile erection in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Organization of diencephalic dopamine neurones projecting to the spinal cord in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

The effect of sildenafil on apomorphine-evoked increases in intracavernous pressure in the awake rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Effect of domperidone on apomorphine-induced growth hormone secretion in normal men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Spinal proerectile effect of oxytocin in anesthetized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Spinal proerectile effect of apomorphine in the anesthetized rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Effect of apomorphine on intracavernous pressure and blood pressure in conscious, spinalized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Peripheral relaxant activity of apomorphine and of a D1 selective receptor agonist on human corpus cavernosum strips.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. The Apomorphine Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Pergolide mesylate can improve sexual dysfunction in patients with Parkinson's disease: the results of an open, prospective, 6-month follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Penile erections and hypersexuality induced by pergolide treatment in advanced, fluctuating Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Dose-induced penile erections in response to ropinirole therapy for Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

The clinical safety of viagra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Sildenafil in the treatment of erectile dysfunction in elderly depressed patients with idiopathic Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Apomorphine as an alternative to sildenafil in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Sexual well being in parkinsonian patients after deep brain stimulation of the subthalamic nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

AC pulsed electromagnetic fields-induced sexual arousal and penile erections in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

Neuroimmunophilins: a novel drug therapy for the reversal of neurodegenerative disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.10.017

10.1016/J.UROLOGY.2005.10.017

7 January 2021

Identifiers

DOI

1 reference

14 August 2017

1 reference